I don't think it makes sense if it's just radiopharm, but if it's "cancer based" radiology read focus and/or radiosensitizers/immunotherapy then okay. But radiology is probably not going to want us to do reads, medonc won't want us to do immunotherapy. The lowest hanging fruit is radiopharm.
Current RadOncs are more than educated enough to provide radiopharm. Techs deliver it manually, not the RadOncs, just dose prescribing and symptom management. We already study cell biology and radiation. We manage radiation symptoms. Many radiology trained deliverers of these therapies end up just consenting for the admission of the therapy and then the rest of the care is left up to MedOnc and internal medicine.
The last thing RadOncs need is more unnecessary training.